Vaxcyte, Inc. (PCVX)
54.24
-1.24
(-2.24%)
USD |
NASDAQ |
Mar 18, 15:59
54.07
-0.16
(-0.30%)
After-Hours: 17:11
Vaxcyte Total Assets (Quarterly) : 3.046B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co., Inc. | 136.87B |
| Corcept Therapeutics, Inc. | 838.03M |
| Cytokinetics, Inc. | 1.425B |
| Rhythm Pharmaceuticals, Inc. | 481.19M |
| Sutro Biopharma, Inc. | 209.66M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 360.46M |
| Shareholders Equity (Quarterly) | 2.686B |
| Debt to Equity Ratio | 0.0437 |
| Current Ratio | 7.909 |
| Net Debt Paydown Yield | -0.30% |